Enteral vancomycin and probiotic use for methicillin-resistant Staphylococcus aureus antibiotic-associated diarrhoea.
ISBN or ISSN
BMJ Case Rep
Publication Date / Copyright Date
B M J Group
A geriatric patient status post intraabdominal surgery presented with persistent diarrhoea and heavy intestinal methicillin-resistant Staphylococcus aureus (MRSA) growth after multiple courses of antibiotic therapy. Additionally, swab cultures of the anterior nares tested positive for MRSA. In order to impede infection and prevent future complications, the patient received a 10-day course of vancomycin oral solution 250 mg every 6 h, 15-day course of Saccharomyces boulardii 250 mg orally twice daily and a 5-day course of topical mupirocin 2% twice daily intranasally. Diarrhoea ceased during therapy and repeat cultures 11 days after initiating therapy demonstrated negative MRSA growth from the stool and nares. Further repeat cultures 5 months later revealed negative MRSA growth in the stools and minimal MRSA growth in the nares. Overall, enteral vancomycin and probiotics successfully eradicated MRSA infection without intestinal recurrence. Although the results were beneficial treating MRSA diarrhoea for our patient, these agents remain highly controversial.
Medical Specialties | Medicine and Health Sciences | Osteopathic Medicine and Osteopathy
Aged, 80 and over, Anti-Bacterial Agents, Diarrhea, Drug Administration Routes, Drug Administration Schedule, Humans, Male, Methicillin-Resistant Staphylococcus aureus, Probiotics, Staphylococcal Infections, Treatment Outcome, Vancomycin
Sizemore, Elizabeth Nicole; Rivas, Kenya Maria; Valdes, Jose; and Caballero, Joshua, "Enteral vancomycin and probiotic use for methicillin-resistant Staphylococcus aureus antibiotic-associated diarrhoea." (2012). Faculty Articles. 1519.